Pain News and Research

Latest Pain News and Research

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

A modified blood adult stem-cell transplant regimen has effectively reversed sickle cell disease in 9 of 10 adults who had been severely affected by the disease, according to results of a National Institutes of Health study in the Dec. 10 issue of the New England Journal of Medicine.

13 Dec 2009

Phase 2 pivotal trial of AC220 initiated by Ambit Biosciences

Ambit Biosciences Corporation announced today the enrollment and dosing at the University of Texas M. D. Anderson Cancer Center of the first patient in the ACE (AC220 Monotherapy Efficacy) Phase 2 pivotal trial in patients with relapsed or refractory acute myeloid leukemia (AML).

11 Dec 2009

Proteins from catfish venom glands could accelerate wound healing in humans

Lest anyone have concerns about attacks of killer catfish, rest assured that, at least in North America, these finned fatales use their venom mainly to defend themselves against predatory fish, though they can inflict a painful sting that many fishermen have suffered. In other parts of the world, some catfish do have extremely toxic venoms that can be deadly to humans.

11 Dec 2009

University of Maryland School of Nursing to spearhead new Center for Pain Studies

The University of Maryland School of Nursing in Baltimore is "uniquely poised" to spearhead a new collaborative Center for Pain Studies funded by a $2.4 million, five-year federal grant, said Susan Dorsey, PhD, RN, director of the center.

11 Dec 2009

Oconomowoc Memorial Hospital performs partial knee resurfacing surgery using MAKOplasty technology

For the first time in Wisconsin, patients suffering from arthritis pain have access to a new procedure that uses the precision of robotics to perform partial knee resurfacing surgery. The technology, called MAKOplasty®, is a minimally invasive surgical option that results in shorter hospital stays and faster healing than traditional knee surgeries.

11 Dec 2009

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals’ (formerly Abbott’s) Dilaudid® Tablets 2 mg, 4 mg and 8 mg.

11 Dec 2009

Drop in U.S. colorectal cancer deaths

The American Society for Gastrointestinal Endoscopy (ASGE) lauds the recent news of the decline in U.S. colorectal cancer death and incidence rates. The report, released this week, shows that from 1975 to 2000, incidence rates dropped 22 percent and death rates dropped 26 percent.

10 Dec 2009

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Salix Pharmaceuticals, Ltd. today reported that the Company held a pre-NDA meeting on December 8, 2009 with the FDA to discuss the Company’s proposed new drug application (NDA) for rifaximin in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS).

10 Dec 2009

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted the 12-month results of the OrBIT Trial of its Urgent® PC Neuromodulation System that will be published in the January 2010 print edition of THE JOURNAL OF UROLOGY®.

10 Dec 2009

HSA survey reveals drug cost inflation in workers’ compensation is up by 7.5%

Drug cost inflation in workers’ compensation is up 7.5 percent according to Health Strategy Associates’ (HSA) Sixth Annual Survey of Prescription Drug Management in Workers’ Compensation.

10 Dec 2009

NEJM studies lead to drop in vertebroplasty and vertebral augmentation procedures

Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that vertebroplasty and vertebral augmentation (which includes kyphoplasty) procedures have dropped 10% following the August 2009 publication of two studies in the New England Journal of Medicine (NEJM).

10 Dec 2009

Tips to help patients become more active and involved in their health care

A visit to the doctor is a time to talk and learn, and patients play a critical role in their health care, just like doctors, nurses and other caregivers, according to The Joint Commission's "Tips for Your Doctor's Visit" Speak Up™ educational campaign.

10 Dec 2009

Courtney Gamston wins the inaugural 2009 Facts & Comparisons Enhancement Scholarship

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Courtney Gamston of Auburn University’s Harrison School of Pharmacy is the winner of the inaugural 2009 Facts & Comparisons® Enhancement Scholarship.

10 Dec 2009

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

Neurocrine Biosciences, Inc. today announced top-line efficacy and safety results from the Tulip PETAL Study (703 Study), its fifth Phase 2 clinical trial using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.

10 Dec 2009

EC grants orphan drug designation for MP4CO for treating sickle cell disease

Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced that the European Commission (EC) has granted orphan medicinal product designation for MP4CO for the treatment of sickle cell disease.

10 Dec 2009

New protein discovery may serve as potential marker of drug addiction

Scientists are adding additional brush strokes to the revolutionary new image now emerging for star-shaped cells called astrocytes in the brain and spinal cord. Their report, which suggests a key role for astrocytes in morphine's ability to relieve pain and cause addiction, appears online in ACS' Journal of Proteome Research, a monthly publication.

10 Dec 2009

Low doses of lidocaine given intravenously help control pain after ambulatory surgery procedures

Although lidocaine is most often used as a local anesthetic, low doses of lidocaine given intravenously can help to control pain after common ambulatory surgery procedures, suggests a study in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).

10 Dec 2009

USC Fetal Therapy Program achieves improved survival rate in TTTS fetal surgery

A Southern California fetal surgery institute, one of only a handful in the United States, has posted enormously successful rates in treating a dangerous disorder that affects 10 percent of unborn identical twins.

10 Dec 2009

Rx In-Stream to address the unique needs of pharmaceutical industry launched

Tremor Media, the world's largest online video advertising ad network and provider of the Acudeo® video monetization platform to over 1,000 websites, today announced that it has launched Rx In-Stream, the first in-stream advertising solution created to address the unique needs of the pharmaceutical industry.

10 Dec 2009

Additional data from ALS patients enrolled in confirmatory Phase III STAR trial announced

AVANIR Pharmaceuticals, Inc. today announced additional data from the subset of patients with amyotrophic lateral sclerosis (ALS) enrolled in the confirmatory Phase III STAR trial.

9 Dec 2009

Pain News and Research

Latest Pain News and Research

Modified blood adult stem-cell transplant regimen reverses sickle cell disease

Phase 2 pivotal trial of AC220 initiated by Ambit Biosciences

Proteins from catfish venom glands could accelerate wound healing in humans

University of Maryland School of Nursing to spearhead new Center for Pain Studies

Oconomowoc Memorial Hospital performs partial knee resurfacing surgery using MAKOplasty technology

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Drop in U.S. colorectal cancer deaths

Salix Pharmaceuticals discusses proposed rifaximin NDA with the FDA

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

HSA survey reveals drug cost inflation in workers’ compensation is up by 7.5%

NEJM studies lead to drop in vertebroplasty and vertebral augmentation procedures

Tips to help patients become more active and involved in their health care

Courtney Gamston wins the inaugural 2009 Facts & Comparisons Enhancement Scholarship

Results from Tulip PETAL Study of elagolix announced by Neurocrine Biosciences

EC grants orphan drug designation for MP4CO for treating sickle cell disease

New protein discovery may serve as potential marker of drug addiction

Low doses of lidocaine given intravenously help control pain after ambulatory surgery procedures

USC Fetal Therapy Program achieves improved survival rate in TTTS fetal surgery

Rx In-Stream to address the unique needs of pharmaceutical industry launched

Additional data from ALS patients enrolled in confirmatory Phase III STAR trial announced

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in